US 10426817
Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimetics
granted A61KA61K38/1709A61K45/06
Quick answer
US patent 10426817 (Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimetics) held by MacRegen, Inc. expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MacRegen, Inc.
- Grant date
- Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K38/1709, A61K45/06, A61K9/0048